首页> 外文期刊>Chest >A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer
【24h】

A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer

机译:一项双盲安慰剂对照研究,一种特定的磷酸二酯酶III抑制剂奥普利酮预防肺癌肺切除术后患者的房颤。

获取原文
           

摘要

Atrial fibrillation (AF) is the most common complication after lung cancer surgery.
机译:心房颤动(AF)是肺癌手术后最常见的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号